Current cancer research on tumor immunogenetics and cancer-related transplantation biology
Read Online
Share

Current cancer research on tumor immunogenetics and cancer-related transplantation biology

  • 295 Want to read
  • ·
  • 33 Currently reading

Published by U.S. Dept. of Health, Education and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, National Technical Information Service [distributor in [Bethesda, Md.?], Springfield, Va .
Written in English

Subjects:

  • Tumors -- Immunological aspects -- Abstracts

Book details:

Edition Notes

Other titlesTumor immunogenetics and cancer-related transplantation biology
GenreAbstracts
SeriesSpecial listing -- NCI/ICRDB/SL-234, Special listing (International Cancer Research Data Bank) -- NCI/ICRDB/SL-234
ContributionsNational Cancer Institute (U.S.), International Cancer Research Data Bank
The Physical Object
Paginationi, 45 p. ; 28 cm
Number of Pages45
ID Numbers
Open LibraryOL16803661M

Download Current cancer research on tumor immunogenetics and cancer-related transplantation biology

PDF EPUB FB2 MOBI RTF

"PB" "A service of the International Cancer Research Data Bank (ICRDB)." "August " Prepared by: Current Cancer Research Project Analysis Center. Updates: Current cancer research on tumor immunogenetics and cancer-related transplantation biology. NLM ID: [Book]. 1. Author(s): Current Cancer Research Project Analysis Center (U.S.); International Cancer Research Data Bank. Title(s): Current cancer research on tumor immunogenetics and cancer-related transplantation biology/ [prepared for the ICRDB program by the Current Cancer Research Project Analysis Center]. Research Program, Cell Biology and Tumor Biology, Structural and Functional Genomics, Cancer Risk Factors and Prevention, Tumor Immunology, Imaging and Radiooncology, Infection, Inflammation and Cancer, Translational Cancer Research, nobel laureates, nobel prize, Stefan Hell, Harald zur Hausen, Helmholtz Association, The Helmholtz International Graduate School for Cancer Research in . The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations.

Two general mechanisms have been identified that are involved in the silencing of cancer related genes. Genetic alterations, including mutations and deletions, have been known to be involved in tumor suppression for many years. The immune system, a system with an undeniable but complex role in malignancies significantly can influence the face of malignancy with respect to predisposition, nature, prognosis, and response to Cited by: 1. Tumor Biology Research Postdoctoral Fellow at The Methodist Research Institute Company Profile: Since its founding in , The Methodist Hospital, The Methodist Hospital System’s anchor facility, has earned worldwide recognition. Cancer immunology is a branch of immunology that studies interactions between the immune system and the cancer lfcmalta.com is a growing field of research that aims to discover innovative immuno therapies to treat and retard progression of the lfcmalta.com immune system is the body's first line of defense against most diseases and unatural invaders. Journal of Immunobiology.

Our Research; Current: Cancer Biology and Clinical Oncology Cancer Biology and Clinical Oncology. Cancer is a general term for more than diseases that are characterised by the abnormal growth of cells. Cancer affects a large portion of Australians, with one in two diagnosed by the age of An abstract is unavailable. May 25,  · Doctors are always looking for ways to treat patients but at the same time, there are dedicated researchers and teams which work on ways to eradicate the disease. While cancer treatment is being given high priority with modern medical methods, und. Jan 10,  · Current strategies for cancer patient management include the use of genomic and proteomic test results to help guide therapeutic selection. The need for multi-target variant analysis is highlighted by the growing number of novel therapies to treat tumors with specific profiles and the increasing recognition that cancer is an extremely heterogeneous syndrome. Microarray analysis is a Cited by: 8.